Jadenu(®) Substituting Exjade(®) in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles

INTRODUCTION: Due to the chronic nature of chelation therapy and the adverse consequences of iron overload, patient adherence to therapy is an important issue. Jadenu (®) is a new oral formulation of deferasirox (Exjade (®)) tablets for oral suspension. While Exjade(®) is a dispersible tablet that m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Mohamed A, Soliman, Ashraf T, De Sanctis, Vincenzo, Hussein, Radwa M, Al-Okka, Randa, Kassem, Nancy, Ghasoub, Rula, Basha, Ahmed, Nashwan, Abdulqadir J, Adel, Ahmad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223544/
https://www.ncbi.nlm.nih.gov/pubmed/30416696
http://dx.doi.org/10.4084/MJHID.2018.064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223544/
https://www.ncbi.nlm.nih.gov/pubmed/30416696
http://dx.doi.org/10.4084/MJHID.2018.064

Ejemplares similares